Contributions of protein phosphatases PP1, PP2A, PP2B and PP5 to the regulation of tau phosphorylation
- PMID: 16262633
- DOI: 10.1111/j.1460-9568.2005.04391.x
Contributions of protein phosphatases PP1, PP2A, PP2B and PP5 to the regulation of tau phosphorylation
Abstract
Abnormal hyperphosphorylation of tau is believed to lead to neurofibrillary degeneration in Alzheimer's disease (AD) and other tauopathies. Recent studies have shown that protein phosphatases (PPs) PP1, PP2A, PP2B and PP5 dephosphorylate tau in vitro, but the exact role of each of these phosphatases in the regulation of site-specific phosphorylation of tau in the human brain was unknown. Hence, we investigated the contributions of these PPs to the regulation of tau phosphorylation quantitatively. We found that these four phosphatases all dephosphorylated tau at Ser199, Ser202, Thr205, Thr212, Ser214, Ser235, Ser262, Ser396, Ser404 and Ser409, but with different efficiencies toward different sites. The K(m) values of tau dephosphorylation catalysed by PP1, PP2A and PP5 were 8-12 microm, similar to the intraneuronal tau concentration of human brain, whereas the K(m) of PP2B was fivefold higher. PP2A, PP1, PP5 and PP2B accounted for approximately 71%, approximately 11%, approximately 10% and approximately 7%, respectively, of the total tau phosphatase activity of human brain. The total phosphatase activity and the activities of PP2A and PP5 toward tau were significantly decreased, whereas that of PP2B was increased in AD brain. PP2A activity negatively correlated to the level of tau phosphorylation at the most phosphorylation sites in human brains. Our findings indicate that PP2A is the major tau phosphatase that regulates its phosphorylation at multiple sites in human brain. The abnormal hyperphosphorylation of tau is partially due to a downregulation of PP2A activity in AD brain.
Similar articles
-
FTDP-17 missense mutations site-specifically inhibit as well as promote dephosphorylation of microtubule-associated protein tau by protein phosphatases of HEK-293 cell extract.Neurochem Int. 2009 Jan;54(1):14-27. doi: 10.1016/j.neuint.2008.09.014. Epub 2008 Oct 15. Neurochem Int. 2009. PMID: 18992292
-
Tau hyperphosphorylation correlates with reduced methylation of protein phosphatase 2A.Neurobiol Dis. 2008 Sep;31(3):386-94. doi: 10.1016/j.nbd.2008.05.013. Epub 2008 Jul 23. Neurobiol Dis. 2008. PMID: 18586097
-
Over activation of hippocampal serine/threonine protein phosphatases PP1 and PP2A is involved in lead-induced deficits in learning and memory in young rats.Neurotoxicology. 2012 Jun;33(3):370-83. doi: 10.1016/j.neuro.2012.02.014. Epub 2012 Mar 1. Neurotoxicology. 2012. PMID: 22387731
-
Hyperphosphorylation of tau and protein phosphatases in Alzheimer disease.Panminerva Med. 2006 Jun;48(2):97-108. Panminerva Med. 2006. PMID: 16953147 Review.
-
From promiscuity to precision: protein phosphatases get a makeover.Mol Cell. 2009 Mar 13;33(5):537-45. doi: 10.1016/j.molcel.2009.02.015. Mol Cell. 2009. PMID: 19285938 Review.
Cited by
-
MHC Phosphopeptides: Promising Targets for Immunotherapy of Cancer and Other Chronic Diseases.Mol Cell Proteomics. 2021;20:100112. doi: 10.1016/j.mcpro.2021.100112. Epub 2021 Jun 12. Mol Cell Proteomics. 2021. PMID: 34129940 Free PMC article. Review.
-
β-Amyloid regulates leptin expression and tau phosphorylation through the mTORC1 signaling pathway.J Neurochem. 2010 Oct;115(2):373-84. doi: 10.1111/j.1471-4159.2010.06929.x. Epub 2010 Aug 25. J Neurochem. 2010. PMID: 20670375 Free PMC article.
-
Glycogen synthase kinase-3β suppresses the expression of protein phosphatase methylesterase-1 through β-catenin.Aging (Albany NY). 2019 Nov 12;11(21):9672-9688. doi: 10.18632/aging.102413. Epub 2019 Nov 12. Aging (Albany NY). 2019. PMID: 31714894 Free PMC article.
-
Targeting tau protein in Alzheimer's disease.Drugs Aging. 2010 May;27(5):351-65. doi: 10.2165/11536110-000000000-00000. Drugs Aging. 2010. PMID: 20450234 Review.
-
The carboxy-terminal fragment of inhibitor-2 of protein phosphatase-2A induces Alzheimer disease pathology and cognitive impairment.FASEB J. 2010 Nov;24(11):4420-32. doi: 10.1096/fj.10-158477. Epub 2010 Jul 22. FASEB J. 2010. PMID: 20651003 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases